#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15632	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2030	764.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1404	1404	C	924	C	862	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3481	802.6	0	.	n	.	0	T695C	SNP	695	695	T	984	984	C	894	C,T	834,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3481	802.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1626	1626	A	937	A	882	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3481	802.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2260	2260	C	927	C	848	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3481	802.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2334	2334	A	907	A	858	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28038	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3481	802.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2886	2886	C	893	C	835	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1958	folP	852	852	100.0	folP.l15.c4.ctg.1	1412	137.9	1	SNP	p	R228S	1	.	.	682	684	AGC	904	906	AGC	166;165;164	A;G,C,A;C	156;153,1,1;154	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5168	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3492	147.7	1	SNP	p	S91F	0	.	.	271	273	TCC	599	601	TCC	193;194;196	T;C;C	174;175;175	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5168	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3492	147.7	1	SNP	p	D95N	0	.	.	283	285	GAC	611	613	GAC	191;191;192	G,T;A;C	172,1;170;171	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5168	gyrA	2751	2751	99.85	gyrA.l15.c30.ctg.1	3492	147.7	1	SNP	p	D95G	0	.	.	283	285	GAC	611	613	GAC	191;191;192	G,T;A;C	172,1;170;171	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1166	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1231	94.2	0	.	p	.	0	D79N	NONSYN	235	237	GAT	475	477	AAT	168;167;166	A;A;T	156;156;154	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1166	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1231	94.2	0	.	p	.	0	A86T	NONSYN	256	258	GCG	496	498	ACG	183;185;187	A;C;G	168;170;171	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1166	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1231	94.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	553	555	CAC	196;196;199	C;A;C	184;181;185	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1166	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1231	94.2	0	.	p	.	0	S183N	NONSYN	547	549	AGT	787	789	AAT	86;87;87	A;A;T	83;83;82	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1166	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1231	94.2	0	.	p	.	0	M197I	NONSYN	589	591	ATG	829	831	ATA	73;73;74	A;T;A	67;69;70	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1166	mtrR	633	633	97.47	mtrR.l15.c30.ctg.1	1231	94.2	1	SNP	p	G45D	0	.	.	133	135	GGC	373	375	GGC	167;164;165	G;G;C	152;149;150	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5620	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	197.3	1	SNP	p	D86N	0	.	.	256	258	GAC	500	502	GAC	206;204;204	G;A;C	192;187;191	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5620	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	197.3	1	SNP	p	S87I	0	.	.	259	261	AGT	503	505	AGT	206;206;204	A;G;T	192;192;191	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5620	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	197.3	1	SNP	p	S87W	0	.	.	259	261	AGT	503	505	AGT	206;206;204	A;G;T	192;192;191	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5620	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	197.3	1	SNP	p	S87R	0	.	.	259	261	AGT	503	505	AGT	206;206;204	A;G;T	192;192;191	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5620	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2834	197.3	1	SNP	p	S88P	0	.	.	262	264	TCC	506	508	TCC	205;202;203	T;C,A;C	190;190,1;191	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4316	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2535	169.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1443	1445	GGC	212;213;210	G;G;C	200;202;199	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1283	1285	GCA	188;188;187	G;C;A	173;173;172	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1286	1288	ATC	192;193;193	A;T;C	177;177;176	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1298	1300	GTG	201;201;196	G;T,A;G	182;184,1;181	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1298	1300	GTG	201;201;196	G;T,A;G	182;184,1;181	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1802	1804	ACC	213;210;215	A;C;C	194;194;202	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1856	1858	GCG	196;195;190	G;C,G;G	163;148,1;147	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1856	1858	GCG	196;195;190	G;C,G;G	163;148,1;147	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1979	1981	GGC	186;183;181	G;G;C,T	169;168;167,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1988	1990	GGC	168;167;165	G;G;C	148;145;147	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4048	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2358	170.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2006	2008	CCG	136;138;138	C,G;C,G;GCCC,GGCCCCC	99,8;102,1;95,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5898	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3028	194.0	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1577	1579	CTG	227;227;225	C;T;G,A	199;205;201,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2122	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1645	128.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	486	486	C	148	C	128	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	0	.	p	.	0	I45V	NONSYN	133	135	ATT	385	387	GTT	255;254;254	G;T;T	239;237;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	0	.	p	.	0	I75V	NONSYN	223	225	ATT	475	477	GTT	273;279;285	G;T;T	242;237;256	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	0	.	p	.	0	S89T	NONSYN	265	267	AGC	517	519	ACC	282;281;278	A;C;C	254;258;257	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	0	.	p	.	0	I98V	NONSYN	292	294	ATC	544	546	GTC	272;270;270	G;T;C,A	244;240;247,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	0	.	p	.	0	Y213_N214insRYAYRYAY	INS	637	637	T	889	889	T	259	T	243	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	1	SNP	p	G120K	1	.	.	358	360	AAG	610	612	AAG	238;240;236	A;A;G	221;223;220	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	1	SNP	p	A121N	1	.	.	361	363	AAC	613	615	AAC	238;235;233	A;A;C	225;224;222	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3140	porB1b	1038	1038	97.27	porB1b.l15.c17.ctg.1	1459	213.9	1	SNP	p	N121D	0	.	.	361	363	AAC	613	615	AAC	238;235;233	A;A;C	225;224;222	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11556	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4815	239.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2028	2030	AAT	251;253;255	A,C;A;T	235,1;234;238	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1208	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1044	115.1	1	SNP	p	V57M	1	.	.	169	171	ATG	499	501	ATG	243;245;242	A;T;G	229;233;230	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
